Search

everythinglearnresearchcommunity

for

Search:↓

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Women with polycystic ovary syndrome (PCOS) show higher levels of hope, judgement, perspective, and transcendence, and could benefit from positive psychology therapy.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Some women with PCOS have rare genetic variants linked to the condition.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Hyperandrogenism is a common hormonal disorder in women, often linked to PCOS.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Non-daily contraceptives cause fewer side effects and are more satisfying to women, and certain oral contraceptives can treat acne and seborrhoea, with a combination of chlormadinone acetate and ethinyl estradiol being highly effective and safe.

Hair loss led to the diagnosis of Cushing's disease in a patient, showing that hair loss can be a sign of hormonal disorders.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Higher androgen levels during puberty are linked to shorter adult height in boys with Silver-Russell syndrome.

A woman was diagnosed with a rare adrenal gland cancer that did not show usual hormone-related symptoms.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

More research is needed to understand how testosterone is maintained in adult males.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Hidradenitis suppurativa improves with antiandrogen therapy.

A teenage girl with high androgen levels and PCOS developed a rare liver tumor, suggesting a possible link between high androgens and the tumor's growth.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Hair loss improved after removing pituitary tumor.